000 | 01965 a2200481 4500 | ||
---|---|---|---|
005 | 20250513193236.0 | ||
264 | 0 | _c19991124 | |
008 | 199911s 0 0 eng d | ||
022 | _a0953-816X | ||
024 | 7 |
_a10.1046/j.1460-9568.1999.00742.x _2doi |
|
040 |
_aNLM _beng _cNLM |
||
100 | 1 | _aIzquierdo, I | |
245 | 0 | 0 |
_aNovelty causes time-dependent retrograde amnesia for one-trial avoidance in rats through NMDA receptor- and CaMKII-dependent mechanisms in the hippocampus. _h[electronic resource] |
260 |
_bThe European journal of neuroscience _cSep 1999 |
||
300 |
_a3323-8 p. _bdigital |
||
500 | _aPublication Type: Journal Article; Research Support, Non-U.S. Gov't | ||
650 | 0 | 4 |
_a1-(5-Isoquinolinesulfonyl)-2-Methylpiperazine _xadministration & dosage |
650 | 0 | 4 |
_a2-Amino-5-phosphonovalerate _xadministration & dosage |
650 | 0 | 4 |
_aAmnesia, Retrograde _xpsychology |
650 | 0 | 4 | _aAnimals |
650 | 0 | 4 |
_aAvoidance Learning _xphysiology |
650 | 0 | 4 | _aCalcium-Calmodulin-Dependent Protein Kinase Type 2 |
650 | 0 | 4 |
_aCalcium-Calmodulin-Dependent Protein Kinases _xantagonists & inhibitors |
650 | 0 | 4 | _aCarbazoles |
650 | 0 | 4 |
_aCyclic AMP-Dependent Protein Kinases _xantagonists & inhibitors |
650 | 0 | 4 | _aEnvironment |
650 | 0 | 4 |
_aEnzyme Inhibitors _xadministration & dosage |
650 | 0 | 4 |
_aHippocampus _xenzymology |
650 | 0 | 4 |
_aIndoles _xadministration & dosage |
650 | 0 | 4 | _aInjections |
650 | 0 | 4 | _aMale |
650 | 0 | 4 |
_aPsychomotor Performance _xdrug effects |
650 | 0 | 4 |
_aPyrroles _xadministration & dosage |
650 | 0 | 4 | _aRats |
650 | 0 | 4 | _aRats, Wistar |
650 | 0 | 4 |
_aReceptors, N-Methyl-D-Aspartate _xantagonists & inhibitors |
650 | 0 | 4 | _aTime Factors |
700 | 1 | _aSchröder, N | |
700 | 1 | _aNetto, C A | |
700 | 1 | _aMedina, J H | |
773 | 0 |
_tThe European journal of neuroscience _gvol. 11 _gno. 9 _gp. 3323-8 |
|
856 | 4 | 0 |
_uhttps://doi.org/10.1046/j.1460-9568.1999.00742.x _zAvailable from publisher's website |
999 |
_c10467264 _d10467264 |